Sunday, February 2, 2020

Zydus Cadila gets DGCI nod for diabetes treatment drug

Zydus Cadila gets DGCI nod for diabetes treatment drug In India, the drug was previously approved in 2013 for the treatment of hypertriglyceridemia and diabetic dyslipidemia

from Moneycontrol Business News https://ift.tt/2vNlslD

No comments:

Post a Comment

Adani Group stocks slide up to 14% on US SEC heat

Adani Group stocks saw a sharp decline on Friday. This followed news that the US SEC is seeking court permission to email summons to founder...